- Home
- HLIT vs CVAC Comparison
HLIT vs CVAC Comparison
Compare HLIT & CVAC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HLIT
- CVAC
- Stock Information
- Founded
- HLIT 1988
- CVAC 2000
- Country
- HLIT United States
- CVAC Germany
- Employees
- HLIT N/A
- CVAC N/A
- Industry
- HLIT Radio And Television Broadcasting And Communications Equipment
- CVAC Biotechnology: Pharmaceutical Preparations
- Sector
- HLIT Technology
- CVAC Health Care
- Exchange
- HLIT Nasdaq
- CVAC Nasdaq
- Market Cap
- HLIT 1.2B
- CVAC 1.2B
- IPO Year
- HLIT 1995
- CVAC 2020
- Fundamental
- Price
- HLIT $9.90
- CVAC $5.40
- Analyst Decision
- HLIT Buy
- CVAC Hold
- Analyst Count
- HLIT 6
- CVAC 3
- Target Price
- HLIT $12.10
- CVAC $6.83
- AVG Volume (30 Days)
- HLIT 816.5K
- CVAC 381.8K
- Earning Date
- HLIT 10-27-2025
- CVAC 11-11-2025
- Dividend Yield
- HLIT N/A
- CVAC N/A
- EPS Growth
- HLIT 16.91
- CVAC N/A
- EPS
- HLIT 0.58
- CVAC 1.01
- Revenue
- HLIT $689,084,000.00
- CVAC $599,540,810.00
- Revenue This Year
- HLIT N/A
- CVAC N/A
- Revenue Next Year
- HLIT $25.21
- CVAC $23.83
- P/E Ratio
- HLIT $16.77
- CVAC $5.35
- Revenue Growth
- HLIT 24.14
- CVAC 675.15
- 52 Week Low
- HLIT $7.80
- CVAC $2.37
- 52 Week High
- HLIT $15.46
- CVAC $5.72
- Technical
- Relative Strength Index (RSI)
- HLIT 46.64
- CVAC 51.92
- Support Level
- HLIT $9.71
- CVAC $5.35
- Resistance Level
- HLIT $10.84
- CVAC $5.44
- Average True Range (ATR)
- HLIT 0.31
- CVAC 0.03
- MACD
- HLIT -0.09
- CVAC 0.00
- Stochastic Oscillator
- HLIT 16.81
- CVAC 57.63
About HLIT Harmonic Inc.
Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.